OncoTherapy Science, Inc. (TYO:4564)

Japan · Delayed Price · Currency is JPY

20.00

-1.00 (-4.76%)

Jun 3, 2026, 3:30 PM JST

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Cancer Precision Medicine Related Business	806.20M	747.06M	609.69M	1.13B	1.15B
Cancer Precision Medicine Related Business Growth	7.92%	22.53%	-45.84%	-2.52%	325.28%
Pharmaceutical Research and Development and Related Businesses	2.64M	3.29M	698.00K	9.37M	7.33M
Pharmaceutical Research and Development and Related Businesses Growth	-19.73%	370.63%	-92.55%	27.84%	-93.40%
Unallocated Adjustment	-307.00K	-294.00K	-270.00K	-238.00K	-8.50M
Total	808.53M	750.05M	610.12M	1.13B	1.15B
Total Growth	7.80%	22.93%	-46.24%	-1.63%	246.99%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Japan	808.00M	750.00M	610.00M	1.13B	1.15B
Japan Growth	7.73%	22.95%	-46.21%	-1.65%	247.29%
Total	808.00M	750.00M	610.00M	1.13B	1.15B
Total Growth	7.73%	22.95%	-46.21%	-1.65%	247.29%

Source: S&P Global Market Intelligence.